 |
 |
Kyowa Hakko Interim Profits Ahead of Forecast, Full-year Forecasts *...* <http://www.genengnews.com/news/bnitem.aspx?name=1092573XSL_NEWSML_TO_NEWSML_WEB.xml> Genetic Engineering News - Larchmont,NY,USA *...* Yen, or 21.5%, to 12.3 billion Yen largely due to an increase in Pharmaceuticals Business R&D costs related to KW-6002, a treatment for *Parkinson's* disease. *...* ---------------------------------------------------------------------- To sign-off Parkinsn send a message to: mailto:[log in to unmask] In the body of the message put: signoff parkinsn